PhRMA
FEBRUARY 21, 2023
There have been some alarming stories uncovered by the media on ways nonprofit hospitals — many of which participate in the 340B drug pricing program — are taking advantage of the system and their tax-exempt status to boost their bottom lines, at the expense of patients.
Drug Topics
FEBRUARY 21, 2023
With nearly 250,000 kindergarten age children not receiving their recommended vaccines, pediatric health care providers search for solutions.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
FEBRUARY 21, 2023
A bedrock of the U.S. mental health system — a nine-item questionnaire used to spot depression — began not with a doctor, but with a marketing man. Howard Kroplick, now 73 years old and living on Long Island, is obsessed with antique racing cars and, in his storied career in the pharmaceutical industry, crucially urged Pfizer to avoid the word “impotence” when promoting Viagra.
Drug Topics
FEBRUARY 21, 2023
Researchers estimate the protection from COVID-19 reinfection based on the variant and time since a patient's previous infection.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
European Pharmaceutical Review
FEBRUARY 21, 2023
The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabin
Drug Topics
FEBRUARY 21, 2023
The vaccine was 73.2% effective in children aged 6 months to 4 years when administered during the Omicron-dominant phase.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Store News
FEBRUARY 21, 2023
Consumers are obsessed with their hair, whether it be washing, styling, removing or growing. Here are what experts predict will keep sales bouncy in the new year.
European Pharmaceutical Review
FEBRUARY 21, 2023
Included in this issue of European Pharmaceutical Review : FOREWORD Accelerating drug development David Elder, David P Elder Consultancy RAMAN SPECTROSCOPY Shining a light on Raman for microbiological analysis Tim Sandle, Bio Products Laboratory LIMS Overcoming barriers to capturing data in a laboratory Samantha Kanza, University of Southampton ENVIRONMENTAL MONITORING Endotoxin trends: sustainability, automation and beyond Miriam Guest, AstraZeneca UK REGULATORY INSIGHT UPC opt-out – a strateg
Drug Store News
FEBRUARY 21, 2023
Drug Store News interviewed Anita Patel, vice president of pharmacy services development at Walgreens, about how the retailer is utilizing pharmacists in patient care and testing.
Pharmaceutical Technology
FEBRUARY 21, 2023
Pfizer and BioNTech’s Covid-19 vaccine, Comirnaty, had a phenomenal year with forecast sales of $37bn in 2022. Comirnaty is expected to maintain the sales dominance it saw during the Covid-19 pandemic going into the future, with the average annual sales forecast rising by 19% between H1 and H2 2022, according to GlobalData’s Coronavirus Disease 2019 (Covid-19) Sector Forecast: H2 2022 Global Analyst Consensus Sales Forecast report.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Drug Store News
FEBRUARY 21, 2023
Roche Diagnostics and Pfizer are collaborating to offer a new resource that supports consumers, pharmacists and other healthcare professionals by offering access to critical information, including how to locate resources about testing, available trea
STAT
FEBRUARY 21, 2023
An experimental antibody that delivers lethal radiation directly to the bone marrow improved the outcomes of stem cell transplants for older patients with relapsed leukemia — and may change the way transplant medicine is practiced. The antibody-radiation treatment, called Iomab-B, is being developed by Actinium Pharmaceuticals, a small drugmaker based in New York.
Drug Store News
FEBRUARY 21, 2023
Christine Baeder, senior vice president and chief operating officer for U.S. generics, Teva Pharmaceuticals USA is the 2023 AAM chair of the board.
STAT
FEBRUARY 21, 2023
BEIJING — Hong Kong on Tuesday revoked a visa it granted to a Chinese scientist who set off an ethical debate five years ago with claims that he made the world’s first genetically edited babies, pulling it hours after he announced his research plans in the financial hub. He Jiankui shocked the world in 2018 when he announced he had altered the embryos of twin girls, with many in the scientific community criticizing his work as unethical.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Store News
FEBRUARY 21, 2023
Generic Latuda is used to treat a depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients as monotherapy.
Fierce Healthcare
FEBRUARY 21, 2023
Office for Civil Rights brings 2 reports to Congress regarding state of HIPAA compliance and cybersecurity aburky Tue, 02/21/2023 - 14:54
European Pharmaceutical Review
FEBRUARY 21, 2023
SYFOVRE (pegcetacoplan injection) is the first and only treatment approved by the US Food and Drug Administration (FDA) for geographic atrophy (GA), a leading cause of blindness. GA is an advanced form of age-related macular degeneration (AMD). It is a progressive and irreversible disease caused by the growth of lesions, which destroy the retinal cells responsible for vision.
Fierce Healthcare
FEBRUARY 21, 2023
CMS: Tighter price transparency enforcement, standardized requirements for hospitals are on the horizon dmuoio Tue, 02/21/2023 - 15:15
STAT
FEBRUARY 21, 2023
Good morning, everyone, and welcome to another working week. Like many on this side of the pond, we are returning from an extended weekend respite, which we hope was invigorating and relaxing, thanks to a holiday. Now, though, the time has come to return to the usual routine of deadlines, meetings and online calls. But what can you do? The world, such as it is, keeps spinning.
Drug Store News
FEBRUARY 21, 2023
The stores that Kroger and Albertsons reportedly may sell are estimated to be worth more than $1 billion, according to a Reuters report.
Drug Topics
FEBRUARY 21, 2023
Linda Stein Gold, MD explains in nonsteroidal treatment options for plaque psoriasis.
Drug Store News
FEBRUARY 21, 2023
Redcon1’s Total War Black Ops Extreme Pre-Workout is an ultra-dosed product formulated to support extreme and high-intensity workouts.
STAT
FEBRUARY 21, 2023
A Dutch public interest group has filed a lawsuit claiming AbbVie breached a duty to human rights by using unfair and excessive pricing to bolster sales of its Humira drug and dominate the market at the expense of the health care system in the Netherlands. In making its case, the Pharmaceutical Accountability Foundation argued AbbVie allegedly overcharged the Dutch health care system by up to $1.2 billion by “abusing” its position in the marketplace and keeping prices high.
PharmaVoice
FEBRUARY 21, 2023
The rare disease market is set for major growth in the decade to come, and pharma companies are securing their footholds now.
Fierce Healthcare
FEBRUARY 21, 2023
Program promises to take a team approach to tackling severe kidney disease fdiamond Tue, 02/21/2023 - 09:48
Fierce Pharma
FEBRUARY 21, 2023
Merck's COVID pill Lagevrio comes up short in household COVID exposure study kdunleavy Tue, 02/21/2023 - 10:18
Fierce Healthcare
FEBRUARY 21, 2023
Senators urge CMS to rethink narrow Medicare coverage for Alzheimer's drugs pminemyer Tue, 02/21/2023 - 16:17
Fierce Pharma
FEBRUARY 21, 2023
Chasing Pfizer, Alnylam to face FDA Adcomm for Onpattro’s rare heart disease bid aliu Tue, 02/21/2023 - 09:53
Drug Store News
FEBRUARY 21, 2023
The company reported total revenue of $164.0 billion, an increase of 7.3%, or 7.9% in constant currency.
Fierce Pharma
FEBRUARY 21, 2023
Teva gains FDA approval for once-daily formulation of flagship drug Austedo fkansteiner Tue, 02/21/2023 - 15:58
Pharmafile
FEBRUARY 21, 2023
Hemab Therapeutics announced it received $135m from their oversubscribed Series B funding round. The funding will be used for their rare blood disorders programme, which involves lesser-known bleeding disorders. A phase 1/2 trial, looking at Hemab’s lead asset HMB-001 as a treatment for Glanzmann Thrombasthenia, is currently running in the UK. HMB-001 is a bispecific antibody which binds to, stabilises and recruits factor Vlla at the site of vascular injury to help the blood clot.
Fierce Healthcare
FEBRUARY 21, 2023
CMS data: Medicare Advantage enrollment now more than 31M pminemyer Tue, 02/21/2023 - 14:21
Pharmafile
FEBRUARY 21, 2023
CSL, a biotech company, has announced that it has received conditional marketing authorisation (CMA) from the European Commission (EC) for their haemophilia B drug Hemgenix. Hemgenix (etranacogene dezaparvovec) is an adeno-associated virus five (AAV5)-based gene therapy. It is indicated for the treatment of moderately severe to severe haemophilia B without a Factor IX inhibitors history ‒ antibodies which can develop in patients treated with FIX replacement therapies.
ISPE
FEBRUARY 21, 2023
20 Important Quotes That Can Change Your Company’s Culture Trudy Patterson Tue, 02/21/2023 - 15:43 iSpeak Blog iSpeak 20 Important Quotes That Can Change Your Company’s Culture Edyna Miguez 21 February 2023 The 2023 Facilities of the Future Conference Women in Pharma panel welcomed a full room. Seen from left to right: Carolina Serrano (moderator), Kerren Bergman, Vivianne Arencibia and Jessica Ballinger The room filled quickly with members of the pharmaceutical industry of all ages, genders, an
Expert insights. Personalized for you.
231 
Let's personalize your content